618 related articles for article (PubMed ID: 33586518)
1. Plasma d-glutamate levels for detecting mild cognitive impairment and Alzheimer's disease: Machine learning approaches.
Chang CH; Lin CH; Liu CY; Huang CS; Chen SJ; Lin WC; Yang HT; Lane HY
J Psychopharmacol; 2021 Mar; 35(3):265-272. PubMed ID: 33586518
[TBL] [Abstract][Full Text] [Related]
2. Serum vitamin D in patients with mild cognitive impairment and Alzheimer's disease.
Ouma S; Suenaga M; Bölükbaşı Hatip FF; Hatip-Al-Khatib I; Tsuboi Y; Matsunaga Y
Brain Behav; 2018 Mar; 8(3):e00936. PubMed ID: 29541546
[TBL] [Abstract][Full Text] [Related]
3. ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.
Apostolova LG; Hwang KS; Kohannim O; Avila D; Elashoff D; Jack CR; Shaw L; Trojanowski JQ; Weiner MW; Thompson PM;
Neuroimage Clin; 2014; 4():461-72. PubMed ID: 24634832
[TBL] [Abstract][Full Text] [Related]
4. D-glutamate, D-serine, and D-alanine differ in their roles in cognitive decline in patients with Alzheimer's disease or mild cognitive impairment.
Lin CH; Yang HT; Lane HY
Pharmacol Biochem Behav; 2019 Oct; 185():172760. PubMed ID: 31422081
[TBL] [Abstract][Full Text] [Related]
5. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
[TBL] [Abstract][Full Text] [Related]
6. Blood levels of D-amino acid oxidase vs. D-amino acids in reflecting cognitive aging.
Lin CH; Yang HT; Chiu CC; Lane HY
Sci Rep; 2017 Nov; 7(1):14849. PubMed ID: 29093468
[TBL] [Abstract][Full Text] [Related]
7. Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer's Disease.
Chang CH; Lin CH; Lane HY
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33803217
[TBL] [Abstract][Full Text] [Related]
8. Psychometric Properties of Alzheimer's Disease Assessment Scale-Cognitive Subscale for Mild Cognitive Impairment and Mild Alzheimer's Disease Patients in an Asian Context.
Zainal NH; Silva E; Lim LL; Kandiah N
Ann Acad Med Singap; 2016 Jul; 45(7):273-83. PubMed ID: 27523508
[TBL] [Abstract][Full Text] [Related]
9. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities.
Yang H; Cheng Z; Li Z; Jiang Y; Zhao J; Wu Y; Gu S; Xu H
Int J Geriatr Psychiatry; 2019 Nov; 34(11):1658-1666. PubMed ID: 31347192
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory.
Moodley K; Minati L; Contarino V; Prioni S; Wood R; Cooper R; D'Incerti L; Tagliavini F; Chan D
Hippocampus; 2015 Aug; 25(8):939-51. PubMed ID: 25605659
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
[TBL] [Abstract][Full Text] [Related]
12. A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.
Yilmaz A; Ustun I; Ugur Z; Akyol S; Hu WT; Fiandaca MS; Mapstone M; Federoff H; Maddens M; Graham SF
J Alzheimers Dis; 2020; 78(4):1381-1392. PubMed ID: 33164929
[TBL] [Abstract][Full Text] [Related]
13. Optimizing Machine Learning Methods to Improve Predictive Models of Alzheimer's Disease.
Ezzati A; Zammit AR; Harvey DJ; Habeck C; Hall CB; Lipton RB;
J Alzheimers Dis; 2019; 71(3):1027-1036. PubMed ID: 31476152
[TBL] [Abstract][Full Text] [Related]
14. Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease within 5 Years.
Darmanthé N; Tabatabaei-Jafari H; Cherbuin N;
J Alzheimers Dis; 2021; 82(3):951-964. PubMed ID: 34120902
[TBL] [Abstract][Full Text] [Related]
15. Plasma Homocysteine and Serum Folate and Vitamin B
Ma F; Wu T; Zhao J; Ji L; Song A; Zhang M; Huang G
Nutrients; 2017 Jul; 9(7):. PubMed ID: 28698453
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of Mild Cognitive Impairment Using the Thai Version of the Consortium to Establish a Registry for Alzheimer's Disease Tests: A Multivariate and Machine Learning Study.
Tunvirachaisakul C; Supasitthumrong T; Tangwongchai S; Hemrunroj S; Chuchuen P; Tawankanjanachot I; Likitchareon Y; Phanthumchinda K; Sriswasdi S; Maes M
Dement Geriatr Cogn Disord; 2018; 45(1-2):38-48. PubMed ID: 29617684
[TBL] [Abstract][Full Text] [Related]
17. Multiomics Blood-Based Biomarkers Predict Alzheimer's Predementia with High Specificity in a Multicentric Cohort Study.
Souchet B; Michaïl A; Heuillet M; Dupuy-Gayral A; Haudebourg E; Pech C; Berthemy AA; Autelitano F; Billoir B; Domoto-Reilly K; Fowler C; Grabowski T; Jayadev S; Masters CL; Braudeau J
J Prev Alzheimers Dis; 2024; 11(3):567-581. PubMed ID: 38706273
[TBL] [Abstract][Full Text] [Related]
18. Validation of the Chinese version of Addenbrooke's cognitive examination-revised for screening mild Alzheimer's disease and mild cognitive impairment.
Fang R; Wang G; Huang Y; Zhuang JP; Tang HD; Wang Y; Deng YL; Xu W; Chen SD; Ren RJ
Dement Geriatr Cogn Disord; 2014; 37(3-4):223-31. PubMed ID: 24193223
[TBL] [Abstract][Full Text] [Related]
19. Multivariate Data Analysis and Machine Learning for Prediction of MCI-to-AD Conversion.
Skolariki K; Terrera GM; Danso S
Adv Exp Med Biol; 2020; 1194():81-103. PubMed ID: 32468526
[TBL] [Abstract][Full Text] [Related]
20. Increased prediction value of biomarker combinations for the conversion of mild cognitive impairment to Alzheimer's dementia.
Zhao A; Li Y; Yan Y; Qiu Y; Li B; Xu W; Wang Y; Liu J; Deng Y
Transl Neurodegener; 2020 Aug; 9(1):30. PubMed ID: 32741361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
